yahoo.com
Clinical Trials Expand Patients' Treatment Options
Clinical trials expand treatment options and are how new IBD therapies are tested and approved. Low enrollment can delay access to future treatments for Crohn’s and ulcerative colitis.
People with Crohn’s disease or ulcerative colitis, caregivers, clinicians who refer patients, and researchers or advocates involved in trial recruitment.
What To Know
Clinical trials are a key route for new treatments to reach people with Crohn’s disease and ulcerative colitis.
This article summarizes why trials matter, how they’re structured (phases, randomized controlled design), common enrollment challenges, and practical tips for patients interested in joining trials, including talking with clinicians and checking foundation resources like the Crohn’s & Colitis Foundation clinical trials community.
If you’re thinking about a trial, the article emphasizes learning about eligibility, discussing options with your doctor, and using trusted sources to find trials. It does not describe any specific trial, drug, or outcome.
This is a general, educational piece—not new research or a report of trial results—so it’s intended to help patients understand what clinical trials are and how to explore participation.
This is a general patient-education article summarizing established information about clinical trials and encouraging enrollment. It does not report new trial results or provide clinical recommendations. For trial-specific details, consult trial listings and your care team.
